A study of efficacy and safety of 5-aminolevulinic acid phosphate in patients with sideroblastic anemia
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2018
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Sideroblastic anaemia
- Focus Therapeutic Use
- 08 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 07 Sep 2016 Status changed from not yet recruiting to recruiting.
- 17 May 2016 New trial record